Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
  1. 4 Open-market sale President and CEO sold 10,000 shares at $31.75 ($317,500)
  2. 4 Open-market sale Chief Financial Officer sold 5,000 shares at $30.00 ($150,000)
  3. 4 Open-market sale SVP, Technical Operations sold 21,890 shares at $30.04 ($657,576)
  4. 4 Open-market sale SVP, Technical Operations sold 110 shares at $30.00 ($3,300)
  5. 4 Open-market sale SVP, Technical Operations sold 2,000 shares at $29.31 ($58,620)
  6. 4 Open-market sale President and CEO sold 10,000 shares at $27.71 ($277,100)
  7. 4 Open-market sale Chief Financial Officer sold 5,000 shares at $25.30 ($126,500)
  8. 4 Open-market sale President and CEO sold 10,000 shares at an average $32.62 ($326,184)
  9. 4 Open-market sale Chief Financial Officer sold 5,000 shares at $33.25 ($166,250)
  10. 4 Open-market sale Director sold 20,000 shares at $34.95 ($699,000)
  11. 4 Open-market sale Director sold 20,000 shares at $32.45 ($649,000)
  12. 4 Open-market sale President and CEO sold 10,000 shares at an average $29.33 ($293,273)
  13. 4 Open-market sale Director sold 40,000 shares at an average $28.70 ($1,148,000)
  14. 4 Open-market sale Chief Financial Officer sold 5,000 shares at an average $27.39 ($136,925)
  15. 4 Open-market sale Chief Medical Officer sold 27,342 shares at $25.00 ($683,550)
  16. 4 Open-market sale Director sold 20,000 shares at $24.95 ($499,000)
  17. 4 Open-market sale Chief Medical Officer sold 32,658 shares at $25.00 ($816,450)
  18. 4 Open-market sale President and CEO sold 10,500 shares at $25.00 ($262,500)
  19. 4 Exercise or conversion President and CEO acquired 23,530 shares (option exercise)
  20. 4 Open-market sale Chief Medical Officer sold 15,000 shares at $20.03 ($300,450)

Page 17 of 22 · 435 filings